Reckitt benefits from flu season to begin 2013 strongly
LONDON (Reuters) - Reckitt Benckiser reported a strong start to 2013 as the maker of Strepsils lozenges and Mucinex decongestant continued to benefit from a severe United States cold and flu season. Total net revenues in the three months to end-March were 2.52 billion pounds ($3.8 billion), up 7 percent, or 6 percent stripping out its pharmaceuticals unit. Analysts were expecting revenues of 2.47 billion pounds for the quarter, according to Thomson Reuters estimates. In February, Reckitt beat full year profit forecasts, driven in part by the unusually intense cold and flu season. ...
Source: news.yahoo.com
No comments:
Post a Comment